BioSpace39m
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector ...
BioSpace54m
Over Half of Biopharma Professionals Work More Hours Than Average US Workers, BioSpace Finds
Although U.S. full-time employees worked an average of 42.9 hours weekly last year, according to Gallup, that wasn’t true for ...
BioSpace17h
Scott Steele Steps In as FDA’s Interim CBER Head After Marks’ Departure
Following the dramatic late-night resignation of Peter Marks last Friday, Steele, a senior advisor to the division, takes the ...
BioSpace21h
Denali Goes All in On Neuroscience’s Thorniest Hurdle: Crossing the Blood-Brain Barrier
After some high-profile crashes, the one-time biotech darling is inching toward success with its Hunter syndrome treatment, ...
BioSpace22h
FDA Job Cuts, Key Departures Bring ‘Revolving Door’ Debate Front and Center
With the recently announced layoffs of 3,500 FDA staffers and exits of branch directors Patrizia Cavazzoni and Peter Marks, ...
BioSpace22h
Democrats Push Back on Trump Health Cuts With Lawsuits and Longest Ever Senate Speech
Nearly two dozen states on Tuesday sued the Department of Health and Human Services over a planned $11 billion funding cut ...